Data Leak at Ozempic Manufacturer Novo Nordisk
6 hours ago
- #Cyber Extortion
- #Pharmaceutical Security
- #Data Breach
- Cyber gang FulcrumSec accessed Novo Nordisk's internal IT systems, stealing personal and sensitive data.
- The stolen data includes pseudonymized information of around 11,500 clinical trial participants, covering patient ID, gender, year of birth, biomarkers, health data, and lifestyle details.
- FulcrumSec claims to have acquired 4748 source code repositories, drug structures, AI models, employee data, and the recipe for experimental drug Amycretin, totaling 1.3 TB.
- Novo Nordisk confirmed the data leak, stating no directly identifiable patient names were included, and has taken security measures, including temporarily taking some IT systems offline.
- FulcrumSec is demanding a $25 million ransom, but Novo Nordisk refuses to pay, with the company contacting the extortionists after being contacted by them.